logo
Select company
Select metric
1.03%Inventory to Assets Ratio
VS
Market
42
Sector
41
Industry
19
History
63
$ 1.78Close
$ 0.67 - $ 1.82 52-Week Range
Ticker Information

Ticker

CHRS

Company Name

COHERUS ONCOLOGY INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

COHERUS ONCOLOGY INC - Inventory to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CHRS - Inv. to Assets Historical data
DateTotal AssetsInventoryInventory to Assets Ratio
6/30/2025$ 439.46M$ 4.51M1.03%
3/31/2025$ 371.07M$ 3.52M0.95%
12/31/2024$ 448.53M$ 113.87M25.39%
9/30/2024$ 505M$ 119.02M23.57%
6/30/2024$ 674.86M$ 112.04M16.6%
3/31/2024$ 763.54M$ 127.62M16.71%
12/31/2023$ 629.6M$ 130.1M20.66%
9/30/2023$ 583.78M$ 145.78M24.97%
6/30/2023$ 469.59M$ 127.83M27.22%
3/31/2023$ 402.43M$ 114.49M28.45%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • COHERUS ONCOLOGY INC's latest trailing twelve months (TTM) Inv. to Assets stands at 10.7%.
  • Over the past 5 years, COHERUS ONCOLOGY INC's average Inv. to Assets has been 16.96%.
  • The median Inv. to Assets for COHERUS ONCOLOGY INC during this period was 16.66%
  • COHERUS ONCOLOGY INC reached its highest Inv. to Assets over the past 5 years at 28.45%.
  • The lowest Inv. to Assets recorded by COHERUS ONCOLOGY INC in the same timeframe 0.95%

COHERUS ONCOLOGY INC's Inv. to Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Inv. to Assets Benchmarks
CompanyInv. to Assets
MGNX : MACROGENICS INC 3.78%IGMS : IGM BIOSCIENCES INC 0%STRO : SUTRO BIOPHARMA INC 0%AGEN : AGENUS INC 0%ATRA : ATARA BIOTHERAPEUTICS INC 0%CELU : CELULARITY INC 9.83%CSBR : CHAMPIONS ONCOLOGY INC 0%KPTI : KARYOPHARM THERAPEUTICS INC 4.76%IPSC : CENTURY THERAPEUTICS INC 0%IVVD : INVIVYD INC 28.54%

Definition of Inventory to Assets Ratio

[Calculation] [Inventory] as percentage of total [Assets], serves as an efficiency ratio - the lower the better.
Inventory / Assets
(=) Inv. to Assets
Inv. to Assets for COHERUS ONCOLOGY INC is calculated as follows: Inventory [ $ 85.96M ] / Assets [ $ 803.73M ]
(=) Inv. to Assets [ 10.7% ]

CHRS - Inventory to Assets Ratio, Last 5 years

0.95%

Minimum

Mar 31, 2025

28.45%

Maximum

Mar 31, 2023

16.96%

Average

16.66%

Median

Inv. to Assets Benchmark Analysis

The chart above depicts the distribution of Inv. to Assets for companies in the Total Stock Market. The average Inv. to Assets of the companies is 6.09% with a standard deviation of 11.11%.
The following table provides additional summary stats:
Inv. to Assets in the Market:
filtered constituents4.46K
min0%
max98.39%
average6.09%
median0%
std11.11%